Expression and Functional Characterization of Human ABC Transporter ABCG2 Variants in Insect Cells

Drug Metabolism And Pharmacokinetics

Volumn 18, Issue 3, 2003, Pages 194-202

  Ishikawa, Toshihisa ^a   Kasamatsu, Shiho ^a   Hagiwara, Yuko ^a   Mitomo, Hideyuki ^a   Kato, Ryo ^a   Sumino, Yasuhiro ^b,c  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c Pharma SNP Consortium   (Japan)

Author keywords

ABC transporter; ABCG2; BCRP; pharmacogenomics; single nucleotide polymorphism

Indexed keywords

EID: 85009628144     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.18.194     Document Type: Article

References (39)

1. Kalow, W., Meyer, U. A. and Tyndale, R. F. (eds.): Pharmacogenomics, Marcel Dekker, New York (2001).
2. Hesketh, R.: The Oncogene Handbook, Academic Press, London (1994).
3. Ling, V.: Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother. Pharmacol., 40: S3-S8 (1997).
4. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I. and Gottesman, M. M.: Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol., 39: 361-398 (1999).
5. Klein, I., Sarkadi, B. and Váradi, A.: An inventory of the human ABC proteins. Biochim. Biophys. Acta, 1461: 237-262 (1999).
6. Dean, M., Rzhetsky, A. and Allikmets, R.: The human ATP-binding cassette (ABC) transporter superfamily. Genome Res., 11: 1156-1166 (2001).
7. Borst, P. and Oude Elferink, R.: Mammalian ABC transporters in health and disease. Annu. Rev. Biochem., 71: 537-592 (2002).
8. Ishikawa, T.: Multidrug resistance: genomics of ABC transporters. In: Nature Encyclopedia of Human Genome, Nature Publishing Group, London, vol. 4, pp. 154-160 (2003).
9. Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K. and Ross, D. D.: A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA, 95: 15665-15670 (1998).
10. Allikmets, R., Schriml, L. M., Hutchinson, A., Romano-Spica, V. and Dean, M.: A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res., 58: 5337-5339 (1998).
11. Hazlehurst, L. A., Foley, N. E., Gleason-Guzman, M. C., Hacker, M. P., Cress, A. E., Greenberger, L. W., de Jong, M. C. and Dalton, W. S.: Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line. Cancer Res., 59: 1021-1028 (1999).
12. Rabindran, S. K., He, H., Singh, M., Brown, E., Collins, K. I., Annable, T. and Greenberger, L. M.: Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res., 58: 5850-5858 (1998).
13. Miyake, K., Mickley, L., Litman, T., Zhan, Z., Robey, R., Cristensen, B., Brangi, M., Greenberger, L., Dean, M., Fojo, T. and Bates, S. E.: Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res., 59: 8-13 (1999).
14. Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C. A. M., Ruevekamp-Helmers, M. C., Floot, B. G. J. and Schellens, J. H. M.: Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res., 59: 4559-4563 (1999).
15. Ross, D. D., Yang, W., Abruzzo, L. V., Dalton, W. S., Schneider, E., Lage, H., Dietel, M., Greenberger, L., Cole, S. P. C. and Doyle, L. A.: Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J. Natl. Cancer Inst., 91: 429-433 (1999).
16. Brangi, M., Litman, T., Ciotti, M., Nishiyama, K., Kohlhagen, G., Takimoto, C., Robey, R., Pommier, Y., Fojo, T. and Bates, S. E.: Camptothecin resistance: role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation in MXR-expressing cells. Cancer Res., 59: 5938-5946 (1999).
17. Litman, T., Brangi, M., Hudson, E., Fetsch, P., Abati, A., Ross, D. D., Miyake, K., Resau, J. H. and Bates, S. E.: The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J. Cell Sci., 113: 2011-2021 (2000).
18. Nakagawa, R., Hara, Y., Arakawa, H., Nishimura, S. and Komatani, H.: ABCG2 confers resistance to indolocarbazole compounds by ATP-dependent transport. Biochem. Biophys. Res. Commun., 299: 669-675 (2002).
19. Kawabata, S., Oka, M., Shiozawa, K., Tsukamoto, K., Nakatomi, K., Sada, H., Fukuda, M., Tsurutani, J., Ikegami, Y., Sugahara, K., Yamada, Y., Kamihira, S., Doyle, L. A., Ross, D. D. and Kohno, S.: Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem. Biophys. Res. Commun., 280: 1216-1223 (2001).
20. Nakatomi, K., Yoshikawa, M., Oka, M., Ikegami, Y., Hayasaka, S., Sano, K., Shiozawa, K., Kawabata, S., Soda, H., Ishikawa, T., Tanabe, S. and Kohno, S.: Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem. Biophys. Res. Commun., 288: 827-832 (2001).
21. Honjo, Y., Hrycyna, C. A., Yan, Q.-W., Medina-Pérez, W. Y., Robey, R. W., van de Laar, A., Litman, T., Dean, M. and Bates, S. E.: Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. Cancer Res., 61: 6635-6639 (2001).
22. Özvegy, C., Varadi, A. and Sarkadi, B.: Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. J. Biol. Chem., 277: 47980-47990 (2002).
23. Volk, E. L., Farley, K. M., Wu, Y., Li, F., Robey, R. W. and Schneider, E.: Overexpression of wild-type breast cancer resistance protein mediates methotrexate resistance. Cancer Res., 62: 5035-5040 (2002).
24. Yoshikawa, M., Kasamatsu, S., Yasunaga, M., Wang, G., Ikegami, Y., Yoshida, H., Tarui, S., Yabuuchi, H. and Ishikawa, T.: Does ABCG2 need a heterodimer partner? Expression and functional evaluation of ABCG2 (Arg-482). Drug Metabol. Pharmacokin., 17: 130-135 (2002).
25. Laemmli, U. K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227: 680-685 (1970).
26. Carter, S. G. and Karl, D. W.: Inorganic phosphate assay with malachite green: an improvement and evaluation. J. Biochem. Biophys. Methods, 7: 7-13 (1982).
27. Sarkadi, B., Price, E. M., Boucher, R. C., Germann, U. A. and Scarborough, G. A.: Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem., 267: 4854-4858 (1992).
28. Ishikawa, T.: ATP/Mg2+-dependent cardiac transport system for glutathione S-conjugates: A study using rat heart sarcolemma vesicles. J. Biol. Chem., 264: 17343-17348 (1989).
29. Litman, T., Jensen, U., Hansen, A., Covitz, K.-M., Zhan, Z., Fetsch, P., Abati, A., Hansen, P. R., Horn, T., Skovsgaad, T. and Bates, S. E.: Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2. Biochim. Biophys. Acta, 1565: 6-16 (2002).
30. Kage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T. and Sugimoto, Y.: Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization. Int. J. Cancer, 97: 626-630 (2002).
31. Komatani, H., Kotani, H., Hara, Y., Nakagawa, R., Matsumoto, M., Arakawa, H. and Nishimura, S.: Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure. Cancer Res., 61: 2827-2832 (2001).
32. Schlemmer, S. R. and Sirotnak, F. M.: Energy-dependent efflux of methotrexate in L1210 leukemia cells: Evidence for the role of an ATPase obtained with inside-out plasma membrane vesicles. J. Biol. Chem., 267: 14746-14752 (1992).
33. Saxena, M. and Henderson, G. B.: Identification of efflux systems for large anions and anionic conjugates as the mediators of methotrexate efflux in L1210 cells. Biochem. Pharmacol., 51: 974-982 (1996).
34. Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M. and Jansen, G.: Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res., 59: 2532-2535 (1999).
35. Kool, M., van der Linden, M., de Haas, M., Scheffer, G. L., de Vree, J. M., Smith, A. J., Jansen, G., Peters, G. J., Ponne, N., Scheper, R. J., Oude Elferink, R. P., Baas, F. and Borst, P.: MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA, 96: 6914-6919 (1999).
36. Chen, Z.-S., Lee, K., Walther, S., Raftogianis, R. B., Kuwano, M., Zeng, H. and Kruh, G. D.: Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res., 62: 3144-3150 (2002).
37. Mitomo, H., Kato, R., Ito, A., Kasamatsu, S., Ikegami, Y., Kii, I., Kudo, A., Kobatake, E., Sumino, Y. and Ishikawa, T.: A functional study on the polymorphism of ATP-binding cassette transporter ABCG2: critical role of Arg482 in methotrexate transport. Biochem. J., 373: in press (2003).
38. Allen, J. D., Jackson, S. C. and Schinkel, A. H.: A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for doxorubicin resistance. Cancer Res., 62: 2294-2299 (2002).
39. Jonker, J. W., Buitelaar, M., Wagenaar, Els, van der Valk, M., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Oude Elferink, R. P., Rosing, H., Beijnen, J. H. and Schinkel, A. H.: The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc. Natl. Acad. Sci. USA, 99: 15649-15654 (2002).